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Abstract
Background: A 1 mm minilaparoscope (Lifeline Biotechnoligies, Florida, USA) was assessed for
aiding port site insertions.
Methods: Ten consecutive patients having laparoscopic procedures in a gynaecological oncology
unit were included. Minilaparoscopy was feasible in all cases and was used to insert the umbilical
port under direct vision in all patients. In one case, a thick band of abdominal adhesions was
identified and a further lateral port site was inserted to aid their dissection.
Results: The minilaparoscope correctly identified all 10 patients with peritoneal disease and
identified all patients who were suitable for debulking procedures.
Conclusion: Minilaparoscopy with the 1 mm endoscope appears to be safe and accurate and we
feel that it has a place in helping the surgeon identify adhesions and peritoneal disease as well as
assisting further port site insertion safely and with minimal complications.
Background
Laparoscopy can be associated with a risk of visceral dam-
age during primary trocar insertion (1). This is particularly
so in oncology cases where there are likely to be adhesions
and peritoneal malignancy. Microendoscopes work by
transmitting light through fiberoptic bundles rather than
the rigid lens-based system of traditional endoscopes.
Mini laparoscopes have been used to assist port site inser-
tion (2), we describe the use of a new 1 mm mini-laparo-
scope (Ovascope, Lifeline Biotechnoligies, Florida, USA)
to assist primary trocar insertion during gynaecological
oncology surgery.
Methods
Ten consecutive patients who had a minilaparoscopically
guided 1 mm laparoscopy are reported. Minilaparoscopy
was performed using the Ovascope (Lifeline Biotechnoli-
gies, Florida, USA). Patients included gynaecological
oncology patients due to have a laparoscopy. Five patients
(50%) were having laparoscopy for assessment of suitabil-
ity for debulking surgery.
Following informed consent, patients were anesthetised
and placed in a modified Lloyd-Davis position. Insuffla-
tion was primarily performed using a Veress needle at Pal-
mar's point. The trocar from the 1 mm laparoscope was
inserted at Palmar's point and then the mini-laparoscope
was used to assess disease status and assess the presence of
abdominal adhesions. Once a site for safe trocar location
was identified the primary trocar was inserted.
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Results
Five patients (50%) had laparoscopy to assess suitability
of debulking for ovarian cancer. One patient (10%) was
having a laparoscopic colostomy formed as a treatment
for bowel obstruction in recurrent metastatic endometrial
cancer. One patient (10%) was having a laparoscopic
ovarian cystectomy and three (30%) were having bilateral
salpingo-oophrectomy. In terms of co morbidities; six of
the patients had previous mid-line laparotomies, two
patients had previously undergone a laparoscopy, one of
the patients was obese (BMI > 30) and five patients had
ovarian carcinoma.
In all the cases the mini laparoscopy was used to insert the
primary port through the umbilicus under direct vision.
The mini-laparoscope achieved a view successfully in 10
patients (100%). The mini-laparoscope correctly identi-
fied the sites of peritoneal disease 2 patients with omental
involvement. The mini-laparoscope successfully identi-
fied the patients who were suitable for optimal debulking
and showed the absence of peritoneal involvement in all
five patients with ovarian cancer.
In nine patients the primary port was subsequently
inserted under direct vision through the umbilicus. In one
case, the mini- laparoscope identified a thick band of
adhesion over the anterior abdominal wall and a further
laparoscopic port was inserted laterally so that these adhe-
sions could be dissected.
Discussion
The ability to use the microlaparoscope to reassess
patients with ovarian cancer has not been adequately
investigated. One group with a small patient number (n =
8) showed that it is feasible using a 2.8 mm (5), to reduce
the risk of major complications in relation to the blind
insertion of the umbilical trocar as well as provide good
diagnostic accuracy.
Although the technique for inserting the primary trocar in
this way is not new, smaller equipment is becoming
increasingly popular as is all forms of minimally invasive
surgery. This is particularly so as surgeons hope to avoid
larger trocar incisions and their associated complications,
and the wish to perform these laparoscopic procedures in
the outpatient department. Laparoscopy performed under
local anesthetic in the outpatient department has also
been shown to be well tolerated and safe (3). The use of
laparoscopy and minilaparoscopy in both general surgery
and gynaecology has been compared in terms of compli-
cations, pain and recovery (6, 7). No significant difference
was seen in pain scores between groups, but the patients
who underwent minilaparoscopy had shorter stays in hos-
pital, required less analgesia and reported increased satis-
faction with their wounds. However, the minilaparoscope
does have limitations in standard practice. Abdominal
procedures which require a high degree of manipulation,
specialized instruments or larger escape hatches will
require the larger, standard laparoscopic equipment.
Conclusion
This data demonstrates that a new 1 mm laparoscope
(Ovascope, Lifeline Biotechnoligies, Florida, USA) has
value in gynaecological oncology surgery. We feel that it
would be a useful tool to aid primary trocar insertion and
may be of value in identifying peritoneal disease prior to
consideration of debulking surgery. Patients who have
undergone previous surgery have a higher incidence of
umbilical adhesions. High risk groups include those who
have had midline or horizontal incisions for their laparot-
omies (4). These patients might benefit from a prelimi-
nary inspection with the microlaparoscope to rule out
adhesions and therefore decrease the risk of complica-
tions.
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